Literature DB >> 6735637

Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneo-venous shunting. A clinico-pathological report.

D Tarin, A C Vass, M G Kettlewell, J E Price.   

Abstract

This communication records a remarkable case illustrating both the clinical value of peritoneo-venous shunting in the management of malignant ascites, and the unique opportunity afforded by this procedure for investigation of factors which influence metastatic colony formation by disseminating human tumour cells. The study of patients treated with peritoneo-venous shunts for the purpose of obtaining information on metastasis is ethically sound because such treatment is used solely for relief of the patient's clinical condition, and investigative procedures involving the patient are limited to those necessary for good clinical management. The patient we present survived for 27 months following insertion of a peritoneo-venous shunt, and for most of this time had a functioning shunt judged by clinical criteria. At autopsy she was found to have no established metastases in any organ, although viable, clonogenic cancer cells clearly capable of forming large secondary growths in the abdominal cavity were delivered directly into the bloodstream.

Entities:  

Mesh:

Year:  1984        PMID: 6735637

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  7 in total

Review 1.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

2.  SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy.

Authors:  Anh Thu Bui; Fanny Laurent; Maryline Havard; François Dautry; Thierry Tchénio
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Authors:  Andy J Minn; Yibin Kang; Inna Serganova; Gaorav P Gupta; Dilip D Giri; Mikhail Doubrovin; Vladimir Ponomarev; William L Gerald; Ronald Blasberg; Joan Massagué
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts.

Authors:  D Tarin; J E Price; M G Kettlewell; R G Souter; A C Vass; B Crossley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

Review 5.  Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications.

Authors:  Donna H Murrell; Paula J Foster; Ann F Chambers
Journal:  J Mol Med (Berl)       Date:  2013-12-05       Impact factor: 4.599

Review 6.  Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency.

Authors:  A F Chambers; G N Naumov; S A Vantyghem; A B Tuck
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

Review 7.  Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.

Authors:  Maria V Barbolina
Journal:  Cancers (Basel)       Date:  2018-11-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.